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Introduction
The share of health care expenditure (HCE) in GDP rises inexorably, it would seem, in virtually all OECD countries, causing increasing concern among politicians and the general public. Figure 1 illustrates this for a couple of countries for which data are available back to 1960.
<Insert Figure 1 around here>
Starting in the seventies, health economists have sought to explain the reasons behind the surge in health expenditure; but not much consensus has emerged beyond the finding that aggregate HCE is closely correlated with GDP or National Income, respectively (cf. ROBERTS 1999: 459) . Although most studies that include additional explanatory variables, for example variables representing institutional features of health systems, initial levels of health expenditure or population shares above certain age thresholds, find some of them to be statistically significant, these findings are not very robust to varying the testing methodology or the sample of countries or years covered.
1 Furthermore, the choice of explanatory variables has been largely ad hoc (cf. WILSON 1999: 160) . Reviewing the achievements in this field of research for the GERDTHAM/JÖNSSON (2000: 48) conclude that "(w)e need more theory of the macroeconomics of health expenditure, at least relative to the macroeconometrics of health expenditure".
Handbook of Health Economics,
Yet, a well-known model exists that could offer a theoretical explanation for the constant rise in the share of health expenditure in GDP -Baumol's model of 'unbalanced growth'. Although Baumol's (1967) paper introducing this model is widely regarded as a seminal contribution, health economists have been reluctant to embrace his approach. HARTWIG (2006) , in his meta-analysis of research on the determinants of HCE that focuses in the main on English-language top journals, finds only one paper to mention Baumol's model (KARATZAS 2000) and none to test it. (2004) for a recent contribution.
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In a nutshell, 3 Baumol's model states that expenditure shares shift towards the services sector -of which the health care sector forms a part -because of divergent productivity growth between the secondary and the tertiary sectors of the economy.
Baumol assumes that productivity growth is the result of technological innovation which manifests itself in new capital goods. It follows that productivity growth is largely confined to the manufacturing industries since, in most service industries, physical capital cannot be employed on a large scale. Furthermore, Baumol assumes that wages in both the 'progressive' and the 'nonprogressive' sectors grow at the same rate so that unit labor costs in the tertiary sector rise relative to those in the secondary sector. If prices are a mark-up on costs they will grow faster in sector 3 than in sector 2.
What will then happen is a question of the relevant price elasticities of demand. If the price elasticity is high, then the activity will vanish. Baumol (1967: 421) invokes craftsmanship, fine restaurants, and theaters as examples of establishments that have either disappeared or retreated to luxury niches as a consequence of customers' unwillingness to tolerate the price increases that would have been necessary to cover rising costs. The other possibility is that the sector produces necessities for which the price elasticity is low -as the health care sector does. To show what happens in these industries as a consequence of unbalanced growth, Baumol assumes that the relation of real output of the two sectors remains unchanged. Then, an ever larger share of the labor force must move to the tertiary sector (or into unemployment). And because of the divergent growth in unit labor costs combined with mark-up pricing, an ever larger share of nominal GDP will be allotted to the tertiary sector, even though the relation of real output of the two sectors is assumed to remain the same. This shift of expenditures into activities largely financed out of tax money, such as education and health care, has been termed 'Baumol's (cost) Disease' (cf. BAUMOL/TOWSE 1997).
Are Baumol's assumptions warranted for the health sector?
It is sometimes argued that Baumol's assumptions are unwarranted for the health sector. Two lines of argument are put forward to support this view. First, it is disputed that the capital intensity of the health sector is low (as Baumol asserts). As is well known, more and more medical appliances are installed in hospitals, and technical progress is substantial in this field. Therefore, the production of health care services might be as capital-intensive as manufacturing activities -or even more so. half of the total expenditure on hospital services is paid for by the federal states (cantons). The rest is reimbursed by the sickness funds on a fee-for-service base.
Obviously, prices for hospital services would be quite different without the public subsidies. In fact, the 'Cost Disease' can affect the health sector without any rise in medical care prices. In an environment of heavily regulated prices, there are ways to shift resources into this sector other than raising prices. A third difference between the approach of GERDTHAM/JÖNSSON (1991) and that of the present paper is that all variables are here modeled in log differences (growth rates) instead of log levels. In doing so, I follow the recommendation of GERDTHAM/JÖNSSON consider the possibility of structural breaks in the time series. Using data from 20 OECD countries, they find both HCE and GDP to be stationary around one or two structural breaks. The upshot of this debate is that we can't be sure about the degree of integration of health expenditure variables. By specifying the regression in growth rates, we are unlikely to produce spurious results since no-one has proposed that HCE are I(2).
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As has been mentioned, working with pooled data allows for richer specifications including country and time-specific effects. These effects can be captured by introducing either country dummy variables (cross-section fixed-effects) or period dummy variables (period fixed-effects) or both. If, however, the country or periodspecific effect is itself a random variable, it would be appropriate to estimate a randomeffects model. The standard way of choosing between fixed and random-effects models is to run a Hausman test. In our case -contrary to the finding of GERDTHAM (1992) -this test does not reject the null hypothesis that the random effects are uncorrelated with the explanatory variables so that the random-effects estimator is to be preferred. This probably reflects the fact that our sample of 9 countries is drawn somewhat randomly from the group of OECD countries according to data availability.
We will present results of cross-section fixed-effects estimations along with the random-effects estimations, though. The estimation period covers the years from 1971 to 2003. (2004) as well as, of course, Baumol's model.
<Insert Tables 1 and 2 In testing parameter stability over time, I follow GERDTHAM (1992) by splitting the period of observation into three arbitrary sub-periods, namely 1971-1981, 1982-1992, and 1993-2003 . Tables 3a and 3b show that the growth rate of the relative price of health care loses its statistical significance as an explanatory variable for HCE growth in the second sub-period both in the random-effects and fixed-effects models. The estimated coefficient retains a positive sign, though. In the other two periods, the relative price variable remains significant (except in the first period in model 20). If significant, the coefficients are noticeably higher than in the estimation covering the whole observation period.
<Insert Tables 3a and 3b around here>
Per-capita GDP growth is statistically significant mostly at the 1 per cent level. There are somewhat greater differences in the magnitude of the coefficients between the random-effects and the fixed-effects estimations than for the whole period. Also, the explanatory power of the model varies, being lowest for the most recent sub-period.
The second parameter stability test proposed by GERDTHAM (1992) involves varying the sample of countries. To reproduce this test, I re-estimate the model dropping each of the nine countries in turn. This exercise also offers the opportunity to include the Italian and French data that have not been considered so far. Table 3 1971-1981 1982-1992 1993-2003 1971-1981 1982-1992 1993-2003 dlog ( dlog(GDPPC) = log difference of nominal per-capita GDP, dlog(RELPR) = log difference of the price of health care relative to the GDP deflator. The values shown in parenthesis are t-ratios, based on White's robust S.E.s. The Swamy-Arora GLS estimator was used to estimate the random effects models, and weighted diagnostic statistics are reported. * and ** denote significance at the 5 and 1 per cent level, respectively Estimates for constant terms not shown. 
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